Jingkang Shen

This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 6 CIPO patents and 9 EPO patents, primarily in Antibody-Drug Conjugates. Top assignees: Chinese Academy of Sciences, Mitsubishi Tanabe Pharma Corporation, Shanghai Pharmaceuticals Holding Co., Ltd.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jingkang Shen. Retrieved from https://idiyas.com/inventor/jingkang-shen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 2)

% Patents Active = 78.9

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 27(Granted Patents)

Company Filing History:

11 out of 3,358

Chinese Academy of Sciences

patents

4 out of 263

Mitsubishi Tanabe Pharma Corporation

patents

4 out of 11

Shanghai Pharmaceuticals Holding Co., Ltd.

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

patents

6. 2 out of 5

Shanghai Miracogen Inc

patents

7. 2 out of 15

Topharman Shanghai Co., Ltd.

patents

8. 1 out of 1

Jiangsu Mabwell Health Pharmaceutical R&d Co., Ltd.

patent

9. 1 out of 1

Mabwell (Shanghai) Bioscience Co., Ltd.

patent

10. 1 out of 9

Shanghai Haihe Pharmaceutical Co., Ltd.

patents

11. 1 out of 1

Shanghai Lead Discovery Pharmaceuticals Limited Company

patent

12. 1 out of 1

Shanghai Pharmaceuticals Holdings Co., Ltd.

patent

13. 1 out of 1

Shanghai Ringene Biopharma Co., Ltd.

patent

14. 1 out of 4

Topharman Shandong Co., Ltd.

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugate

Aromatic Ring-Lactam

Heterocyclic Compound

Pyrimidine

Pharmaceutical Composition

SARS Coronavirus

Renin Inhibitor

Morpholine Derivative

Dihydroquinoxaline

Quinazoline Derivative

Tetrahydroprotoberberine

Huperzine A

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12715871 - Aromatic ring-lactam compound, preparation method therefor and use thereof (2026-08-25),

2. 12290505 - Tissue factor-targeted antibody-drug conjugate (2025-05-06),

3. 11939386 - AXL-targeting antibody, antibody-drug conjugate, preparation method therefor, and use thereof (2024-03-26),

4. 11655239 - Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof (2023-05-23),

5. 11534495 - Tissue factor-targeted antibody-drug conjugate (2022-12-27),

6. 11078188 - Dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof (2021-08-03),

7. 10987430 - Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereof (2021-04-27),

8. 10316033 - Process of synthesizing substituted pyridine and pyrimidine compound (2019-06-11),

9. 10155731 - Nitrogen-containing saturated heterocyclic compound (2018-12-18),

10. 9988381 - Five-member-heterocycle fused pyridine compounds, method of producing the same, and use thereof (2018-06-05),

11. 9796732 - Pyridopyrimidine or pyrimidopyrimidine compound, prepration method, pharmaceutical composition, and use thereof (2017-10-24),

12. 9556159 - Renin inhibitor (2017-01-31),

13. 9371292 - Quinazoline derivative, preparation method therefor, intermediate, composition and application thereof (2016-06-21),

14. 9278944 - Nitrogen-containing saturated heterocyclic compound (2016-03-08),

15. 8975252 - Morpholine derivative (2015-03-10),

Title: Jingkang Shen: Pioneering Inventor from Shanghai

Introduction: Jingkang Shen is a renowned inventor hailing from Shanghai, China, known for his groundbreaking contributions to various technological fields.

Latest Patents: Jingkang Shen holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Jingkang Shen has worked with leading research institutions and multinational companies, playing a key role in developing cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Jingkang Shen has collaborated with top scientists, engineers, and researchers from around the globe, fostering a culture of innovation and knowledge exchange that has led to numerous successful projects and inventions.

Conclusion: Jingkang Shen's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring the next generation of inventors.

Profile summary based on public USPTO records.